Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

MSCI logo
MSCIMSCI
$5.47M-58.4%
General Dynamics logo
General DynamicsGD
$1.08B+80.1%
Ametek logo
AmetekAME
$154.9M+32.2%
The Travelers Companies logo
The Travelers CompaniesTRV
$763M+25.1%
Rockwell Automation logo
Rockwell AutomationROK
$168M+58.8%
Rockwell Automation logo
Rockwell AutomationROK
$144M+30.3%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Twist Bioscience Corporation (TWST) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $24.8M in Q1 2026.
How has Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?
Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value increased by 9.5% year-over-year, from $22.64M to $24.8M.
What is the long-term trend for Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value has grown at a -59.3% compound annual growth rate (CAGR), from $242.01M to $6.62M.